Resources > Story
Alzheimer's Disease Research

“Help the One You Can”

Meet Mel and Irene Sahyun, donors to BrightFocus' Alzheimer's Disease Research program.

a photo of Mel Sahyun
Mel Sahyun

In 2014, when Irene Sahyun learned she had begun developing dementia, she and her husband Mel already knew something about coping in the wake of a life-altering, incurable diagnosis. Roughly 30 years earlier, the Sahyuns had discovered one of their two sons, who was then in college, was losing his vision due to retinitis pigmentosa. Worse yet, there were no treatments that could even slow the progress of the inherited eye disease.

When Irene expressed the disappointment and helplessness she and Mel were feeling to the couple’s then-pastor, he responded, “Well, if you can’t help the one you love, help the one you can,” Mel recalled.

That advice helped the Sahyuns find hope and purpose by supporting research and getting involved in vision advocacy. Through those efforts, the couple also met and befriended Dr. Diane Bovenkamp, who, like Irene, is originally from Canada.

Following Irene’s dementia diagnosis, “we realized we should use the same model we had when we found out about Michael’s retinitis pigmentosa,” Mel said. By then, Dr. Bovenkamp had moved to BrightFocus Foundation to serve as the Vice President of Scientific Affairs.

“We followed Diane and started supporting Alzheimer’s Disease Research at BrightFocus,” Mel said.

“BrightFocus Foundation’s model of researchers, donors, and people who are affected by the disease all being part of one community, and interacting with one another, is something Irene found particularly worthwhile,” Mel noted.

Both Irene, a former nurse, and Mel, who has a PhD in physical chemistry, have also appreciated BrightFocus’ emphasis on keeping donors and supporters up to date on the latest research. “Communicating the science to me is very important,” said Mel. “It’s an area I’m not expert in, but I still want to know what’s going on.”

That experience prompted Mel to encourage others who are affected by Alzheimer’s and related dementias to consider supporting BrightFocus’ Alzheimer’s Disease Research program. “I think that’s where the action is as far as supporting research into dementias,” he said.

This story originally appeared in BrightFocus Foundation’s 2025 annual report.

About BrightFocus Foundation

BrightFocus Foundation is a premier global nonprofit funder of research to defeat Alzheimer’s, macular degeneration, and glaucoma. Since its inception more than 50 years ago, BrightFocus and its flagship research programs—Alzheimer’s Disease Research, Macular Degeneration Research, and National Glaucoma Research—has awarded more than $300 million in research grants to scientists around the world, catalyzing thousands of scientific breakthroughs, life-enhancing treatments, and diagnostic tools. We also share the latest research findings, expert information, and resources to empower the millions impacted by these devastating diseases. Learn more at brightfocus.org.

Disclaimer: The information provided here is a public service of BrightFocus Foundation and is not intended to constitute medical advice. Please consult your physician for personalized medical, dietary, and/or exercise advice. Any medications or supplements should only be taken under medical supervision. BrightFocus Foundation does not endorse any medical products or therapies.

Share this post